Your Messages Inbox
Your Article Summary
See Latest ArticlesThe Board of Active Biotech AB proposes that the Annual General Meeting resolve to make a guaranteed rights issue of approximately SEK 256 M
Active Biotech, 04/07/09
Active Biotech has five projects in clinical phase, of which laquinimod and RhuDex(TM) are managed and financed by partners. The clinical projects that are managed and financed on a proprietary basis are TASQ, 57-57 and ANYARA. The potential value of the projects increases in pace with their advancement in clinical development, thereby continuously raising shareholder value. In 2009/2010, new information and clinical data will be published relating to all three of these projects.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Successful purchase of trait platform with extensive product pipeline
BayNews International, 11/06/09
Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
Cell Therapeutics, 11/04/09
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Quality of trials reported as conference abstracts in China: How well are they reported
International Journal of Technology Assessment in Health Care, 11/05/09
User Groups Prove Helpful
HealthDataManagement, 11/03/09
Salix Pharmaceuticals Reviews American Association For The Study Of Liver Diseases Annual Meeting
Salix Pharmaceuticals, 11/03/09
Article Search
Sponsor